Cyclerion Therapeutics
CYCN
CYCN
56 hedge funds and large institutions have $40.7M invested in Cyclerion Therapeutics in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
46% less capital invested
Capital invested by funds: $75.8M → $40.7M (-$35.1M)
Holders
56
Holding in Top 10
–
Calls
$705K
Puts
$108K
Top Buyers
| 1 | +$754K | |
| 2 | +$601K | |
| 3 | +$471K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$428K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$129K |
Top Sellers
| 1 | -$4.93M | |
| 2 | -$436K | |
| 3 | -$280K | |
| 4 |
D.E. Shaw & Co
New York
|
-$234K |
| 5 |
Two Sigma Advisers
New York
|
-$217K |